Inventor · disambiguated record
Praveen Mudunuri
Also filed as: MUDUNURI PRAVEEN
11 granted patents·8 pending applications·479 citations·filing 2008–2018
93Inventor score
Top patents by PatentIndex Score
19 records- 0198US8623894B2Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3-carboxamideVERTEX PHARMA·Filed 2012·Granted Jan 7, 2014·76 cites·3 claims
- 0298US8362253B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2012·Granted Jan 29, 2013·95 cites·11 claims
- 0397US8163772B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamideDEMATTEI JOHN·Filed 2008·Granted Apr 24, 2012·119 cites·56 claims
- 0496US8785476B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2012·Granted Jul 22, 2014·72 cites·9 claims
- 0594US8471029B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideAREKAR SNEHA G·Filed 2011·Granted Jun 25, 2013·85 cites·15 claims
- 0691US9856284B2Solid forms of a thiophosphoramidate nucleotide prodrugALIOS BIOPHARMA INC·Filed 2016·Granted Jan 2, 2018·5 cites·20 claims
- 0788US10039761B2Co-crystals and pharmaceutical compositions comprising the sameVERTEX PHARMA·Filed 2016·Granted Aug 7, 2018·4 cites·21 claims
- 0887US10716789B2Co-crystals and pharmaceutical compositions comprising the sameVERTEX PHARMA·Filed 2018·Granted Jul 21, 2020·3 cites·22 claims
- 0986US9771361B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Sep 26, 2017·8 cites·48 claims
- 1086US9394330B2Solid forms of a thiophosphoramidate nucleotide prodrugALIOS BIOPHARMA INC·Filed 2014·Granted Jul 19, 2016·7 cites·43 claims
- 1183US8916538B2Solid forms of a thiophosphoramidate nucleotide prodrugVERTEX PHARMA·Filed 2013·Granted Dec 23, 2014·5 cites·28 claims
- 1260US2014329855A1Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 1358US2019038615A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 1457US2013338188A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 1557US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 1656US2018153874A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 1756US2013018071A1Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 1852US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 1949US2016067239A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →